BBSRC Portfolio Analyser
Award details
The roles of CD40 and CD154 in haematopoiesis and immunological tolerance
Reference
S12053
Principal Investigator / Supervisor
Dr Anne-Marie Buckle
Co-Investigators /
Co-Supervisors
Institution
The University of Manchester
Department
Life Sciences
Funding type
Research
Value (£)
73,756
Status
Completed
Type
Research Grant
Start date
01/10/2000
End date
22/04/2002
Duration
19 months
Abstract
CD450 may be expressed early in murine B cell ontogeny and be down-regulated at the immature stage. Self reactive immature B cells are eliminated in the marrow following antigen (Ag) receptor ligation, and CD40 ligation prevents this. B cells reactive with CD154 would be activated in the periphery, thus they must be deleted in the bone marrow by Ag receptor ligation by CD154. However in the presence of CD154 a CD40 expressing cell would be rescued. We propose CD40 is down-regulated at the immature stage to allow elimination of those potentially harmful B cells with Ag receptors which bind CD154 or possibly other T cell activation antigens. The proposed study will test this hypothesis. (Joint grant with 50/S12061)
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
Associated awards:
S12061 The roles of CD40 and CD154 in haematopoiesis and immunological tolerance
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search